Author:
Hu Xiawei,Tang Yaning,Fang Xiangming
Abstract
Abstract
Background
Remimazolam is an ultra-short-acting intravenous benzodiazepine, which has been used as sedative/anesthetic in procedural sedation and anesthesia. Although peri-operative anaphylaxis due to remimazolam has been reported recently, the spectrum of the allergic reactions is still not fully known.
Case presentation
We describe a case of anaphylaxis following remimazolam administration in a male patient undergoing colonoscopy under procedural sedation. The patient presented complex clinical signs including airway changes, skin symptoms, gastrointestinal manifestations and hemodynamic fluctuations. Different from other reported cases, laryngeal edema was the initial and main clinical feature of remimiazolam-induced anaphylaxis.
Conclusions
Remimazolam-induced anaphylaxis has a rapid onset and complex clinical features. This case reminds anesthesiologists should be particularly alert to the unknown adverse reactions of new anesthetics.
Publisher
Springer Science and Business Media LLC
Subject
Anesthesiology and Pain Medicine
Reference10 articles.
1. Muraro A, Worm M, Alviani C, et al. EAACI guidelines: Anaphylaxis (2021 update). Allergy. 2022;77:357–77.
2. Tsurumi K, Takahashi S, Hiramoto Y, Nagumo K, Takazawa T, Kamiyama Y. Remimazolam anaphylaxis during anesthesia induction. J Anesth. 2021;35:571–5.
3. Yamaoka M, Kuroda K, Matsumoto N, et al. Remimazolam anaphylaxis confirmed by serum tryptase elevation and skin test. Anaesth Rep. 2022;10: e12167.
4. Kim KM, Lee H, Bang JY, Choi BM, Noh GJ. Anaphylaxis following remimazolam administration during induction of anaesthesia. Br J Anaesth. 2022;129:e122–4.
5. Hasushita Y, Nagao M, Miyazawa Y, Yunoki K, Mima H. Cardiac arrest following remimazolam-induced anaphylaxis: a case report. A A Pract. 2022;16: e01616.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献